Skip to content
Open access · CC-BY via OpenAlex

Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease

Juan F. Reyes, Sara Ekmark‐Lewén, Μarina Perdiki, Therése Klingstedt, Alana Hoffmann, Emilia Wiecheć, Per Nilsson, K. Peter R. Nilsson, Irina I. Alafuzoff, Martin Ingelsson, Martin Hallbeck

Acta Neuropathologica Communications · 2021 · ▲ 59 citations

Abstract

Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson's disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating evidence now indicates that α-syn deposition is also present within the gut and other peripheral organs outside the central nervous system (CNS). In the current study, we demonstrate for the first time that α-syn pathology also accumulates within the liver, the main organ responsible for substance clearance and detoxification. We further demonstrate that cultured human hepatocytes readily internalize oligomeric α-syn assemblies mediated, at least in part, by the gap junction protein connexin-32 (Cx32). Moreover, we identified a time-dependent accumulation of α-syn within the liver of three different transgenic (tg) mouse models expressing human α-syn under CNS-specific promoters, despite the lack of α-syn mRNA expression within the liver. Such a brain-to-liver transmission route could be further corroborated by detection of α-syn pathology within the liver of wild type mice one month after a single striatal α-syn injection. In contrast to the synucleinopathy models, aged mice modeling AD rarely show any amyloid-beta (Aß) deposition within the liver. In human post-mortem liver tissue, we identified cases with neuropathologically confirmed α-syn pathology containing α-syn within hepatocellular structures to a higher degree (75%) than control subjects without α-syn accumulation in the brain (57%). Our results reveal that α-syn accumulates within the liver and may be derived from the brain or other peripheral sources. Collectively, our findings indicate that the liver may play a role in the clearance and detoxification of pathological proteins in PD and related synucleinopathies.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1186/s40478-021-01136-3
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Reyes, J.F., Ekmark‐Lewén, S., Perdiki, �., Klingstedt, T., Hoffmann, A., Wiecheć, E., Nilsson, P., Nilsson, K.P.R., Alafuzoff, I.I., Ingelsson, M., &amp; Hallbeck, M. (2021). Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease. <em>Acta Neuropathologica Communications</em>. https://doi.org/10.1186/s40478-021-01136-3
Vancouver
Reyes JF, Ekmark‐Lewén S, Perdiki �, Klingstedt T, Hoffmann A, Wiecheć E, et al. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease. Acta Neuropathologica Communications. 2021. doi:10.1186/s40478-021-01136-3.
BibTeX
@article{juan2021Accumu, title = {Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease}, author = {Juan F. Reyes and Sara Ekmark‐Lewén and Μarina Perdiki and Therése Klingstedt and Alana Hoffmann and Emilia Wiecheć and Per Nilsson and K. Peter R. Nilsson and Irina I. Alafuzoff and Martin Ingelsson and Martin Hallbeck}, journal = {Acta Neuropathologica Communications}, year = {2021}, doi = {10.1186/s40478-021-01136-3}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings